<p>Acquired Immune Deficiency Syndrome (AIDS) is a late stage of infection with the Human Immune Deficiency Virus (HIV). It can affect both adults and children often predisposing them to opportunistic infections and certain malignancies. Co-infection with tuberculosis (TB) and Hepatitis B are particularly frequent in HIV infected individuals and must be screened for in all cases.</p><p>The main risk factors for HIV/AIDS remain transmission by exchange of body fluids and blood products through sexual contact, transfusion, needle-stick injury, non-sterile surgical practices and mother to child transfer.</p><p>HIV infection is currently not curable. However, for persons living with HIV infection (PLHIV), effective anti-retroviral therapy (ART) is available country-wide at accredited centres at the regional and district level in both public and private health care facilities to which all diagnosed patients must be referred.</p><p>Prevention of infection remains the key to reducing its spread.</p><p><strong>CAUSES</strong></p><ul><li>Human Immunodeficiency Virus</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Persistent cough</li><li>Persistent or recurrent diarrhoea</li><li>Weight loss</li><li>Skin rashes</li><li>Persistent or recurrent fever</li><li>Mouth ulcers</li></ul><p><strong>SIGNS</strong></p><ul><li>Weight loss</li><li>Chronic diarrhoea</li><li>Prolonged fever</li><li>Generalised lymphadenopathy</li><li>Oropharyngeal candidiasis</li><li>Persistent cough</li><li>Generalised dermatitis</li><li>Recurrent herpes zoster (adults)</li><li>Chronic progressive and disseminated herpes simplex infections (adults)</li><li>Finger nail changes e.g. blue discoloration of the nails (adults)</li><li>Failure to thrive or slow growth (infants and children)</li><li>Recurrent common infections e.g. otitis media, pharyngitis (infants and children)</li></ul><p><strong>INVESTIGATIONS</strong></p><ul><li>Confirmatory HIV test (HIV1, HIV2, HIV1 and 2)</li><li>HIV Viral load</li><li>CD4 count</li><li>Other tests as required (See Table 17-1 on page )d (See Table 17-1 on page )d (See Table 17-1 on page 462)</li></ul><figure class="table"><table><tbody><tr><td colspan="2"><strong>Table 17-1: Other baseline tests for HIV</strong></td></tr><tr><td>Haematological test</td><td>Full blood count</td></tr><tr><td>Biochemical test</td><td><p>Blood Urea</p><p>Electrolytes and Creatinine Liver Function tests Fasting Blood Sugar</p><p>Cholesterol and lipid profile</p></td></tr><tr><td>Routine examinations</td><td>Urinalysis (Urine R/E) Stool R/E</td></tr><tr><td>Respiratory examinations</td><td>TB screening Chest X-ray</td></tr><tr><td>Serological Test</td><td>Serological Test Hepatitis B Surface antigen</td></tr><tr><td>Supplementary tests These tests are performed depending on signs and symptoms</td><td><p>Histology on skin and lymph node biopsy Kidney biopsy</p><p>Screening for STIs Pregnancy test</p><p>Pap smear, HPV DNA</p></td></tr></tbody></table></figure><p>&nbsp;</p><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To suppress HIV replication to as low as possible and for as long as possible</li><li>To preserve and enhance the immune function (CD4 restoration)</li><li>To improve quality of life</li><li>To reduce morbidity and mortality related to HIV</li><li>To promote growth and neurological development in children.</li></ul><p><strong>A.&nbsp;Standard Treatment</strong></p><p>1st Line Treatment</p><figure class="table"><table><tbody><tr><td colspan="3"><strong>Table 17-2: Standard Treatment (1st Line Treatment) for HIV-AIDS</strong></td></tr><tr><td>Medicines</td><td>Caution</td><td>Comment</td></tr><tr><td colspan="3"><p>&nbsp;</p><p>Preferred Regimen</p></td></tr><tr><td>Tenofovir (TDF) + Lamivudine (3TC) (or Emtricitabine) + Efavirenz (EFV)</td><td>Caution with Tenofovir in renal dysfunction</td><td>Monitor renal function including Urinalysis</td></tr><tr><td colspan="3"><p>&nbsp;</p><p>Alternative Regimen</p></td></tr><tr><td><p>Tenofovir + Lamivudine (or Emtricitabine (FTC))</p><p>+ Nevirapine (NVP)</p></td><td>Caution with Tenofovir in renal dysfunction Nevirapine is contraindicated in liver dysfunction and NVP hypersensitivity</td><td><p>Monitor renal function including urinalysis</p><p>Stop NVP if client develops jaundice or severe rashes and refer to ART centre for further management.</p></td></tr><tr><td>Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP)</td><td>Zidovudine is contraindicated in severe anaemia Nevirapine is contraindicated in liver dysfunction and NVP hypersensitivity</td><td><p>TDF to be used where Hb is &lt; 8 g/ dL or drops &gt;25% from the baseline value in a client on AZT.</p><p>Stop NVP if client develops jaundice or severe rashes and refer to ART centre for further management</p></td></tr><tr><td>Zidovudine (AZT) + Lamivudine (3TC) + Efavirenz (EFV)</td><td>Zidovudine is contraindicated in severe anaemia</td><td>TDF to be used where Hb is &lt; 8 g/ dL or drops &gt;25% from the baseline value in a client on AZT.</td></tr></tbody></table></figure><p>2nd Line Treatment</p><figure class="table"><table><tbody><tr><td colspan="3"><strong>Table 17-3: Standard Treatment (2nd Line Treatment) for HIV-AIDS</strong></td></tr><tr><td>&nbsp;</td><td>Medicines</td><td>Comments</td></tr><tr><td>First Alternative</td><td><p>Zidovudine +&nbsp;</p><p>Lamivudine (or</p><p>Emtricitabine) +</p><p>Lopinavir/r (or</p><p>Atazanavir/r)</p></td><td><p>If TDF based first line.</p><p>If LPV/r was used for HIV2 in firstline, use ATV/r</p></td></tr><tr><td>Second Alternative</td><td><p>Tenofovir +</p><p>Lamivudine (or</p><p>Emtricitabine) +</p><p>Lopinavir/r (or</p><p>Atazanavir/r)</p></td><td><p>If ZDV based first line.</p><p>Consider Abacavir if patient has used both Tenofovir and Zidovudine</p></td></tr></tbody></table></figure><p>&nbsp;</p><p><strong>B. Special conditions</strong></p><figure class="table"><table><tbody><tr><td colspan="3"><strong>Table 17-4: Standard Treatment in special conditions for HIV-AIDS</strong></td></tr><tr><td>Condition</td><td>Recommendation</td><td>Comments</td></tr><tr><td>HIV co-infection with Hepatitis B (See section on '<a href="acute_hepatitis.html">Hepatitis B</a>')</td><td>The recommended regimen shall be: Lamivudine + Tenofovir + Efavirenz</td><td>Lamivudine and Tenofovir are active against both HBV and HIV</td></tr><tr><td>Dual HIV-1 and HIV-2 or HIV-2 infections</td><td>Due to the ineffectiveness of non-nucleoside drugs (Nevirapine and Efavirenz) in HIV-2 infection combination of nucleosides and protease inhibitors such as LPVr or ATV/r should be used.</td><td>&nbsp;</td></tr></tbody></table></figure><p><strong>REFERRAL CRITERIA</strong></p><p>Refer all HIV positive patients to an accredited treatment centre in Ghana.</p>